Future Biome
Website unreachable since Oct 24, 2026
This biotechnology company develops customized fungal precision prebiotics to improve gut health. They offer a data-driven approach, enabling customers to enhance their gut microbiome through personalized solutions.
- Biotechnology
Funding
Founders
Product
Problem
Many individuals suffer from low-grade chronic inflammation, which is a major contributor to gut health issues, metabolic disorders, mental health challenges, and weakened immunity. Traditional prebiotics often focus solely on digestive wellness, neglecting the broader impact of the microbiome on overall health. Current prebiotic solutions may also have undesirable side effects or unpredictable outcomes.
Solution
Future Biome is developing precision prebiotics derived from fungi to promote a balanced and healthy gut microbiome. Their BiotaBliss product line offers targeted support for the entire microbiome, extending benefits beyond digestive health to include mental clarity, metabolic function, and immune support. Using a predictive platform, Future Biome customizes fungal precision prebiotics for individual microbiomes or target segments, aiming for predictable effects at lower doses and reduced side effects. The company leverages its understanding of the gut microbiota's role in preventing inflammatory diseases to create novel therapies that boost and support microbiota function.
Target Audience
The primary target audience includes healthcare providers, pharmaceutical companies, and nutrition partners seeking innovative solutions for microbiome health and overall wellness.
Features
- Fungi-based prebiotics for targeted microbiome support
- Predictive platform for customizing prebiotic solutions
- Lower dose formulations to minimize side effects
- Support for mental health, metabolic function, and immune system in addition to gut health
- Products designed to address low-grade chronic inflammation